We are a small critical access hospital that does not have on site pharmacy services 24:7. We follow the TJC standard "to a tee" and do not stock concentrated electrolytes outside of the pharmacy, including potassium phosphate. We are routinely called in from home to mix potassium phosphate (or sodium phosphate) infusions. Something I read recently made me think... can't we safety store this concentrated electrolyte outside of the pharmacy in a secured location in the form of a kit with clear instructions for use? Does anyone else do this?

Hello,
Can you share what your institution is doing in light if the SWFI shortage?
Thank you!

Has anyone had reports of inflammatory reactions at the site of injection with Hemabate? We've had three in the last few months. Could it be related to the temperature of Hemabate at the time of injection? Thanks

Hello all,

I help oversee 23 different hospitals associated with our hospital organization. We recently standardized our meds in our crash carts across all our sites, however one thing that was overlooked were RSI kits/meds.

Some sites have RSI kits in a separate drawer in their crash cart (not the same as the code meds), others have them stored in their ADC. We are leaning towards no RSI kits/meds in the crash cart due to some recurrent errors (administering RSI meds inappropriately) but also struggle with some sites not having enough space to store an RSI kit separately.

Hello,
How is your organization addressing Med Rec in the outpatient setting? Our providers are concerned with completing an accurate Med Rec, as well as, the Regulatory and Legal implications if incorrect/or missing a medication.

Could you let me know how your organization views and completes the Outpatient Med Rec?

We are in the process of evaluating our medication administration guidelines that were historically developed for the inpatient setting and how they are applied to the ambulatory infusion setting.

For example, in the infusion center patients may receive alteplase lock flushes (Cathflo), but not alteplase infusions or bolus doses. Does your institution have drug specific guidelines for the ambulatory infusion setting or a policy/guideline with guiding principles for what can be administered in the infusion room setting that you would be willing to share?

Hi everyone -

We are planning for some changes in administration of alteplase given a shortage of 100mg vials. The manufacturer recommendations note to place into an empty bag but that is not a typical bedside process for us. Has anyone investigated other options? Or have plans for safeguards for the bedside transfer to bag?

Thanks

Hi everyone -

We are planning for some changes in administration of alteplase given a shortage of 100mg vials. The manufacturer recommendations note to place into an empty bag but that is not a typical bedside process for us. Has anyone investigated other options? Or have plans for safeguards for the bedside transfer to bag?

Thanks

Hi everyone -

We were made aware of an upcoming shortage of alteplase and are reviewing approaches for safeguarding administration with the use of 50mg vials. The manufacturer recommendations are to place product in empty bags however that's not a typical bedside process at our institution. Has anyone been reviewing alternative or options? And/or what types of safeguards are being employed for the bedside prep by manufacturer instructions?

Thanks

When you compound your chemotherapy preparations, do you account for overfill vs the final labeled volume?
1. Remove "estimated" volume of overfill.
2. Add "estimated" volume of overfill to the final volume on the label.
3. Pump bags to exact base fluid volume stated on the label.
4. Do not account for overfill in the final volume stated on the label.